NanoViricides Reports Excellent Safety Profile of Its First Drug Candidate in Dermal Treatment Study - P&T Community https://t.co/DgnGySDgLr
— Discovery Institute (@discoverynj) March 6, 2019
from Twitter https://twitter.com/discoverynj
March 05, 2019 at 10:04PM
No comments:
Post a Comment